June 30, 2026 · Form 4 insider transaction
RAMSAY DAVID A sold 5,408 shares of Halozyme Therapeutics, Inc. at $78.27 per share, a transaction worth $423.3K. The trade was recorded as shares withheld for taxes and disclosed on an SEC Form 4, filed 2 days after the transaction.
The reported disposition of 5,408 shares represents the shares that were withheld by the issuer as payment for tax withholding obligations.